Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies. Jef Akst was managing editor of ...

Broadly neutralizing antibodies (bNAbs) were first discovered in the '90s when it was observed that HIV-infected individuals possessed antibodies that could recognize and neutralize different subtypes ...

Immunotherapy. 2014;6(1):51-57. Broadly neutralizing antibodies have also been tested on maternal and infant HIV-1 variants, to determine their efficacy on mother to child transmission.

"These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. It also could lead to changes in HIV vaccine schedules, potentially ...

Get Instant Summarized Text (Gist) An HIV vaccine candidate has been developed that effectively guides immune cells to evolve into broadly neutralizing antibodies (bnAbs). In mouse studies, the ...

"These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. It also could lead to changes in HIV vaccine schedules, potentially ...

The results showed that the immunogen successfully activated diverse precursors of what's known as an HIV V3-glycan broadly neutralizing antibody -- antibodies that target a crucial vulnerability ...

“These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. “Minor changes between each dose could create just enough ...